Tuberculosis vaccine trial shows disappointing resultsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f765 (Published 06 February 2013) Cite this as: BMJ 2013;346:f765
- Anne Gulland
A clinical trial of one of the first tuberculosis vaccines to be developed in nearly 100 years has shown disappointing results in protecting children against the disease.
A paper published by the Lancet showed that the modified vaccinia Ankara virus expressing antigen 85A (MVA85A), the most advanced of 12 candidate vaccines currently in clinical trials, showed an efficacy rate of less than 20%.1
Hopes for the vaccine had been high, as previous small trials had shown that the vaccine generated a good immune response in adults.2
The only available vaccine against tuberculosis, BCG, first used in 1921, has highly variable results. It protects against …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial